Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Murex Diagnostics/Organon Teknika

This article was originally published in The Gray Sheet

Executive Summary

Permanently enjoined from manufacturing and selling hepatitis C virus immunoassays that infringe patents held by Chiron, according to a Nov. 29 ruling by the High Court of Justice for England and Wales on a suit brought by Chiron and its marketing partner, Johnson & Johnson's Ortho Diagnostic Systems. Murex said it will appeal the judge's decision to stay the injunction and "will sustain an annual negative revenue impact of $3 mil. on sales of hepatitis C products in the U.K. pending the outcome of the appeal." Damages will be determined at a future hearing
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT003164

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel